We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+31.86%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
AUM
$319M
AUM Growth
Cap. Flow
+$291M
Cap. Flow %
91.41%
Top 10 Hldgs %
6.07%
Holding
629
New
628
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$2.05M
2
JKHY icon
Jack Henry & Associates
JKHY
+$1.99M
3
AKAM icon
Akamai
AKAM
+$1.98M
4
JNPR
Juniper Networks
JNPR
+$1.9M
5
QCOM icon
Qualcomm
QCOM
+$1.86M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 18.43%
2 Technology 17.77%
3 Consumer Discretionary 14.34%
4 Industrials 13.38%
5 Financials 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
601
Ford
F
$56.8B
$95K 0.03%
+10,840
New +$90.8K
IFRX icon
602
InflaRx
IFRX
$262M
$90K 0.03%
+17,887
New +$80.5K
SPPI
603
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$90K 0.03%
+26,388
New +$109K
GORO icon
604
Goldgroup Mining Inc.
GORO
$165M
$85K 0.03%
+29,259
New +$90.8K
USX
605
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$81K 0.03%
+11,781
New +$92K
CYCN icon
606
Cyclerion Therapeutics
CYCN
$15.2M
$78K 0.02%
+1,282
New +$87.4K
SLCA
607
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$75K 0.02%
+10,628
New +$46.2K
EXTR icon
608
Extreme Networks
EXTR
$4.23B
$74K 0.02%
+10,738
New +$57.7K
STSA
609
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$64K 0.02%
+13,908
New +$59.9K
FLL icon
610
Full House Resorts
FLL
$82.7M
$61K 0.02%
+15,441
New +$48.5K
EVC icon
611
Entravision Communication
EVC
$1.07B
$60K 0.02%
+21,955
New +$53.1K
DVAX
612
DELISTED
Dynavax Technologies
DVAX
$59K 0.02%
+13,171
New +$59.6K
ESTE
613
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$53K 0.02%
+10,024
New +$34.7K
CAPR icon
614
Capricor Therapeutics
CAPR
$241M
$52K 0.02%
+15,188
New +$65.9K
BW icon
615
Babcock & Wilcox
BW
$1.51B
$50K 0.02%
+14,105
New +$44.2K
SNGX icon
616
Soligenix
SNGX
$5.59M
$50K 0.02%
+163
New +$74.8K
GRTS
617
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$49K 0.02%
+12,415
New +$37.5K
AIXC
618
AIxCrypto Holdings Inc
AIXC
$16.1M
$48K 0.02%
+32
New +$62.6K
SXC icon
619
SunCoke Energy
SXC
$753M
$46K 0.01%
+10,539
New +$44.1K
NINE
620
DELISTED
Nine Energy Service
NINE
$44K 0.01%
+16,337
New +$30K
LPTH icon
621
Lightpath Technologies
LPTH
$784M
$40K 0.01%
+10,277
New +$29.6K
CBIO
622
Crescent Biopharma
CBIO
$608M
$38K 0.01%
+102
New +$35.7K
CDTX
623
DELISTED
Cidara Therapeutics
CDTX
$36K 0.01%
+897
New +$44.6K
ETTX
624
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$36K 0.01%
+14,442
New +$28.4K
CTIC
625
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$35K 0.01%
+10,882
New +$36.2K

Similar funds

Occudo Quantitative Strategies's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Occudo Quantitative Strategies, which disclosed 629 positions worth $319M. Its ten largest holdings account for 6.1% of the portfolio.

Its largest position is Danaher: 10,223 shares worth $2.01M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, followed by Technology and Consumer Discretionary.

  • Occudo Quantitative Strategies's largest Q4 2020 buy was Danaher: 10,223 shares worth $2.01M.
  • Occudo Quantitative Strategies's ten largest holdings make up 6.1% of its $319M portfolio in Q4 2020.
  • Occudo Quantitative Strategies disclosed 629 positions in Q4 2020, its first 13F filing on record.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.